Ram Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ram Kumar has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed M. Seedat
Family Medicine, Dow University of Health Sciences, Karachi, PAK
1 shared publication - Aishath Shausha Farooq
Ziauddin University, Pakistan
1 shared publication - Ali Shah
Internal Medicine, Jinnah Sindh Medical University, Karachi, PAK
1 shared publication - Amna Ghouri
Dow University of Health Sciences, Pakistan
1 shared publication - Awais Ahmed Mulla
Dow University of Health Sciences, Pakistan
1 shared publication - Besham Kumar
Internal Medicine, Jinnah Postgraduate Medical Centre, Karachi, PAK
1 shared publication
Latest Publications
- Open Access
- 11 September 2023
- Published by Green Publication
- Vol. 30 (17) , 1299-1306
MAGNETIC RESONANCE IMAGING ALTERATION OF THEBRAIN IN APATIENT WITH CORONAVIRUS DISEASE 2019(COVID-19) ANDANOSMIA
Magnetic resonance imaging (MRI) is a non-invasive medical imaging technique that uses a strong magnetic field and radio waves to produce detailed images of internal body structures. Recent studies have shown that COVID-19 infection can lead to alterations in brain structure and function, which can be detected using MRI. The main objective of this meta-analysis is to find the magnetic resonance imaging alteration of the brain in a patient with COVID-19 and anosmia. For this study, Preferred Reporting Items guideline for conducting this meta-analysis was followed. Electronic articles from January 2020 to January 2023 were searched on PUB Med, online Willey library, and ScienceDirect site. At the start, the initial symptoms of selected studies were noted. During analysis the main symptoms of Covid infected patients were fever and dry cough, decrease in the count of white blood cells and lymphocyte count, and increase the frequency of C-reactive protein among the affected patients. The meta-analysis may reveal that COVID-19 patients with anosmia have a significantly higher likelihood of experiencing MRI alterations in certain brain regions compared to COVID-19 patients without anosmia. In conclusion, this meta-analysis highlights the consistent magnetic resonance imaging (MRI) alterations observed in COVID-19 patients with anosmia, indicating the potential involvement of the central nervous system (CNS) in COVID-19 pathophysiology. The observed MRI alterations may be related to direct viral invasion, immune-mediated damage, or disruption of the blood-brain barrier.
- 11 September 2023
- Published by Green Publication
- Vol. 30 (17) , 1299-1306
Open AccessMAGNETIC RESONANCE IMAGING ALTERATION OF THEBRAIN IN APATIENT WITH CORONAVIRUS DISEASE 2019(COVID-19) ANDANOSMIA
Magnetic resonance imaging (MRI) is a non-invasive medical imaging technique that uses a strong magnetic field and radio waves to produce detailed images of internal body structures. Recent studies have shown that COVID-19 infection can lead to alterations in brain structure and function, which can be detected using MRI. The main objective of this meta-analysis is to find the magnetic resonance imaging alteration of the brain in a patient with COVID-19 and anosmia. For this study, Preferred Reporting Items guideline for conducting this meta-analysis was followed. Electronic articles from January 2020 to January 2023 were searched on PUB Med, online Willey library, and ScienceDirect site. At the start, the initial symptoms of selected studies were noted. During analysis the main symptoms of Covid infected patients were fever and dry cough, decrease in the count of white blood cells and lymphocyte count, and increase the frequency of C-reactive protein among the affected patients. The meta-analysis may reveal that COVID-19 patients with anosmia have a significantly higher likelihood of experiencing MRI alterations in certain brain regions compared to COVID-19 patients without anosmia. In conclusion, this meta-analysis highlights the consistent magnetic resonance imaging (MRI) alterations observed in COVID-19 patients with anosmia, indicating the potential involvement of the central nervous system (CNS) in COVID-19 pathophysiology. The observed MRI alterations may be related to direct viral invasion, immune-mediated damage, or disruption of the blood-brain barrier.
- Open Access
- 22 August 2019
- Published by Springer Nature in Cureus
- Vol. 11 (8) , e5465
Sensorineural Hearing Loss and Its Relationship with Duration of Chelation Among Major β-Thalassemia Patients
Introduction Thalassemia is a common genetic disorder worldwide, also occurring frequently in Karachi, Pakistan. Beta (β)-thalassemia major patients need repeated transfusions which cause iron overload. Patients are treated with chelating agents to reduce the high serum ferritin level and to decrease morbidity and mortality due to increased iron levels. This combined therapy also leads to some complications. One of them is the sensorineural hearing loss (SNHL). To date, no data is available in Pakistan regarding SNHL among major β-thalassemia patients on chelating therapy. Methods A cross-sectional study was performed in collaboration with the Thalassemia Center and Dr. Ruth Pfau at the Department of Ear, Nose, and Throat, Civil Hospital, Karachi, Pakistan. The variable to detect hearing was pure tone air and bone conduction thresholds at the frequencies of 250 - 4,000 Hz. Clinical data, such as chelating agent dose, duration, and hearing status, were recorded. Demographic characteristics, like age, gender, height, and weight, were noted. The hemoglobin and serum ferritin levels of the subjects were also included. Results Forty-five percent of cases of thalassemia were suffering from SNHL. In the right ear, the Pearson correlation of chelating agent dose (mg) with SNHL was mildly positive and statistically significant (r = 0.261, p < 0.001), (r = 0.337, p < 0.001), (r = 0.198, p = 0.005), and (r = 0.207, p = 0.003) at the frequencies of 250, 500, 1,000, and 2,000 Hz, respectively, and the Pearson correlation of chelating agent used (in months) with SNHL was mildly positive and statistically significant (r = 0.232, p = 0.001), and (r = 0.301, p < 0.001) at frequencies 250 to 500 Hz, respectively. In the left ear, the Pearson correlation of chelating agent dose (mg) with SNHL was mildly positive and statistically significant, (r = 0.191, p = 0.007), (r = 0.202, p = 0.004), (r = 0.297, p < 0.001), (r = 0.183, p = 0.010) and (r = 0.221, p = 0.002) at frequencies 250, 500, 1,000, 2,000, and 4,000 Hz, respectively, and Pearson correlation of chelating agent used (months) with SNHL was mildly positive and statistically significant only at the frequency of 2,000 Hz (r = 140, p = 0.049). Conclusion Chelation therapy and regular blood transfusions, apart from prolonging the life of thalassemic patients, also leads to some complications. With this survey, it was concluded that almost half of the patients had normal hearing, while the other half had sensorineural hearing loss after the use of deferasirox. It is inferred that the incidence of SNHL is not only dose-related but the duration of use of a chelating agent is also a contributing factor.
- 22 August 2019
- Published by Springer Nature in Cureus
- Vol. 11 (8) , e5465
Open AccessSensorineural Hearing Loss and Its Relationship with Duration of Chelation Among Major β-Thalassemia Patients
Introduction Thalassemia is a common genetic disorder worldwide, also occurring frequently in Karachi, Pakistan. Beta (β)-thalassemia major patients need repeated transfusions which cause iron overload. Patients are treated with chelating agents to reduce the high serum ferritin level and to decrease morbidity and mortality due to increased iron levels. This combined therapy also leads to some complications. One of them is the sensorineural hearing loss (SNHL). To date, no data is available in Pakistan regarding SNHL among major β-thalassemia patients on chelating therapy. Methods A cross-sectional study was performed in collaboration with the Thalassemia Center and Dr. Ruth Pfau at the Department of Ear, Nose, and Throat, Civil Hospital, Karachi, Pakistan. The variable to detect hearing was pure tone air and bone conduction thresholds at the frequencies of 250 - 4,000 Hz. Clinical data, such as chelating agent dose, duration, and hearing status, were recorded. Demographic characteristics, like age, gender, height, and weight, were noted. The hemoglobin and serum ferritin levels of the subjects were also included. Results Forty-five percent of cases of thalassemia were suffering from SNHL. In the right ear, the Pearson correlation of chelating agent dose (mg) with SNHL was mildly positive and statistically significant (r = 0.261, p < 0.001), (r = 0.337, p < 0.001), (r = 0.198, p = 0.005), and (r = 0.207, p = 0.003) at the frequencies of 250, 500, 1,000, and 2,000 Hz, respectively, and the Pearson correlation of chelating agent used (in months) with SNHL was mildly positive and statistically significant (r = 0.232, p = 0.001), and (r = 0.301, p < 0.001) at frequencies 250 to 500 Hz, respectively. In the left ear, the Pearson correlation of chelating agent dose (mg) with SNHL was mildly positive and statistically significant, (r = 0.191, p = 0.007), (r = 0.202, p = 0.004), (r = 0.297, p < 0.001), (r = 0.183, p = 0.010) and (r = 0.221, p = 0.002) at frequencies 250, 500, 1,000, 2,000, and 4,000 Hz, respectively, and Pearson correlation of chelating agent used (months) with SNHL was mildly positive and statistically significant only at the frequency of 2,000 Hz (r = 140, p = 0.049). Conclusion Chelation therapy and regular blood transfusions, apart from prolonging the life of thalassemic patients, also leads to some complications. With this survey, it was concluded that almost half of the patients had normal hearing, while the other half had sensorineural hearing loss after the use of deferasirox. It is inferred that the incidence of SNHL is not only dose-related but the duration of use of a chelating agent is also a contributing factor.
- Open Access
- 18 August 2019
- Published by Springer Nature in Cureus
- Vol. 11 (8) , e5418
Invasive versus Non-invasive Positive Pressure Ventilation In Chronic Obstructive Pulmonary Disease Complicated By Acute Respiratory Failure
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is frequently encountered as a medical emergency. AECOPD is the third leading medical cause of hospitalization due to acute respiratory failure (ARF). The utilization of ventilators for patients with ARF secondary to AECOPD has increased. There has been a major inclination towards utilization of non-invasive positive pressure ventilation (NIPPV) and sparing invasive positive pressure ventilation (IPPV) for life-threatening respiratory distress and/or in patients where NIPPV failure is observed. The aim of this observational study was to compare the clinical and laboratory parameters patients with chronic obstructive pulmonary disease (COPD) complicated by ARF admitted in the intensive care unit (ICU). In the prospective observational study with known cases of COPD complicated by ARF, patients were grouped into NIPPV and IPPV groups based on their clinical and laboratory parameters. Thirty patients were included in each group. Demographic data was collected. Clinical and laboratory parameters were evaluated at baseline and at 24 hours of ventilation. The outcome was assessed in terms of duration of ventilation, hospital and ICU stay and overall mortality. Data was entered and analyzed using SPSS version 22.0 (IBM Corp., Armonk, NY). Both IPPV and NIPPV groups demonstrated marked reduction in partial pressure of carbon dioxide (PaCO2) with 24 hours of ventilation (for IPPV: 78.1 ± 20.2 vs. 69.1 ± 20.2; p=0.08) (for NIPPV: 68.1 ± 17.8 vs. 57.2 ± 21.5; p=0.03). In NIPPV group, there was significant improvement in partial pressure of oxygen (PaO2) (p=0.009), respiratory rate (p=0.008), heart rate (p<0.0001), systolic blood pressure (p=0.03), and diastolic blood pressure (p<0.0001). These parameters did not improve significantly in the IPPV group except for systolic blood pressure (p=0.008). The NIPPV failure rate was 20%. NIPPV patients had a significantly shorter duration of ventilation, ICU stay, and hospital stay. In-ICU mortality was significantly lower in the NIPPV group as compared to IPPV (13% vs. 40%; p=0.01). There was no difference in post-ICU in-hospital mortality between the two groups (6.7% vs. 16.7%; p=0.13). Both NIPPV and IPPV are effective in normalizing acidosis and hypercapnia in patients with COPD complicated by ARF. Patients managed with non-invasive mode of ventilation have a shorter duration of ICU as well as hospital stay. Survival rates are also better as compared to patients managed with invasive ventilation.
- 18 August 2019
- Published by Springer Nature in Cureus
- Vol. 11 (8) , e5418
Open AccessInvasive versus Non-invasive Positive Pressure Ventilation In Chronic Obstructive Pulmonary Disease Complicated By Acute Respiratory Failure
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is frequently encountered as a medical emergency. AECOPD is the third leading medical cause of hospitalization due to acute respiratory failure (ARF). The utilization of ventilators for patients with ARF secondary to AECOPD has increased. There has been a major inclination towards utilization of non-invasive positive pressure ventilation (NIPPV) and sparing invasive positive pressure ventilation (IPPV) for life-threatening respiratory distress and/or in patients where NIPPV failure is observed. The aim of this observational study was to compare the clinical and laboratory parameters patients with chronic obstructive pulmonary disease (COPD) complicated by ARF admitted in the intensive care unit (ICU). In the prospective observational study with known cases of COPD complicated by ARF, patients were grouped into NIPPV and IPPV groups based on their clinical and laboratory parameters. Thirty patients were included in each group. Demographic data was collected. Clinical and laboratory parameters were evaluated at baseline and at 24 hours of ventilation. The outcome was assessed in terms of duration of ventilation, hospital and ICU stay and overall mortality. Data was entered and analyzed using SPSS version 22.0 (IBM Corp., Armonk, NY). Both IPPV and NIPPV groups demonstrated marked reduction in partial pressure of carbon dioxide (PaCO2) with 24 hours of ventilation (for IPPV: 78.1 ± 20.2 vs. 69.1 ± 20.2; p=0.08) (for NIPPV: 68.1 ± 17.8 vs. 57.2 ± 21.5; p=0.03). In NIPPV group, there was significant improvement in partial pressure of oxygen (PaO2) (p=0.009), respiratory rate (p=0.008), heart rate (p<0.0001), systolic blood pressure (p=0.03), and diastolic blood pressure (p<0.0001). These parameters did not improve significantly in the IPPV group except for systolic blood pressure (p=0.008). The NIPPV failure rate was 20%. NIPPV patients had a significantly shorter duration of ventilation, ICU stay, and hospital stay. In-ICU mortality was significantly lower in the NIPPV group as compared to IPPV (13% vs. 40%; p=0.01). There was no difference in post-ICU in-hospital mortality between the two groups (6.7% vs. 16.7%; p=0.13). Both NIPPV and IPPV are effective in normalizing acidosis and hypercapnia in patients with COPD complicated by ARF. Patients managed with non-invasive mode of ventilation have a shorter duration of ICU as well as hospital stay. Survival rates are also better as compared to patients managed with invasive ventilation.
- Open Access
- 1 December 2018
- Published by Elsevier in Indian Heart Journal
- Vol. 70, S199-S203
Frequency and predictors of depression in congestive heart failure
- 1 December 2018
- Published by Elsevier in Indian Heart Journal
- Vol. 70, S199-S203
Open AccessFrequency and predictors of depression in congestive heart failure